Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K
Psychosurgery01:30

Psychosurgery

2.2K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.2K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging Utility of Multimodal Large Language Models in Cardiovascular Diagnostics.

Journal of medical systems·2026
Same author

A Schedule Shift, Not a Federal Green Light: What Cannabis Rescheduling to Schedule III Would Mean-and What It Would Not.

Cannabis and cannabinoid research·2026
Same author

Advancing Cannabis Research in a Changing Landscape: Meeting Summary of the 2025 California Cannabis Research Workshop.

Cannabis and cannabinoid research·2026
Same author

Rewarding Productivity, Hoping for Creativity.

Anesthesiology·2026
Same author

Integrating Pain Prehabilitation into Surgical Pathways: Current Modalities, Outcomes, and Research Gaps.

Current pain and headache reports·2026
Same author

Intraoperative Distractions: The Unknown Unknowns.

World journal of surgery·2026
Same journal

Successful Use of Electroconvulsive Therapy in Treatment-Resistant Catatonia With Comorbid Parkinson Disease and Neuroborreliosis: A Case Report.

The journal of ECT·2026
Same journal

Electroconvulsive Therapy in Movement Disorders: A Systematic Review.

The journal of ECT·2026
Same journal

Presyncope During Repetitive Transcranial Magnetic Stimulation With Treatment Continuation.

The journal of ECT·2026
Same journal

Comparison of Electroconvulsive Therapy Seizure Outcomes When Using Methohexital Versus Propofol: A Brief Retrospective Report.

The journal of ECT·2026
Same journal

Changes in the Use of Repetitive Transcranial Magnetic Stimulation Therapy Between 2016 and 2022 in Northern Finland.

The journal of ECT·2026
Same journal

Evaluation of Cardiac Adverse Effects After Transition From Bitemporal to Bifrontal ECT.

The journal of ECT·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

10.6K

Electroconvulsive Therapy Considerations for Transgendered Patients.

Billy K Tran1, Stephen E O'Donnell, Agnes Balla

  • 1From the Departments of *Anesthesiology, †Pathology and Laboratory Medicine, and ‡Orthopaedics and Rehabilitation, University of Vermont College of Medicine, Burlington, VT.

The Journal of ECT
|December 24, 2016
PubMed
Summary
This summary is machine-generated.

Transgender patients on estrogen therapy may experience prolonged paralysis after succinylcholine use during electroconvulsive therapy (ECT). Anesthesiologists must adjust succinylcholine dosage due to reduced pseudocholinesterase activity in these patients.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.8K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

686

Related Experiment Videos

Last Updated: Mar 9, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

10.6K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.8K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

686

Area of Science:

  • Anesthesiology
  • Endocrinology
  • Pharmacology

Background:

  • Transgender patients require specialized healthcare awareness.
  • Succinylcholine is a neuromuscular blocker used in electroconvulsive therapy (ECT).
  • Pseudocholinesterase enzyme activity affects succinylcholine's duration of action.

Observation:

  • A male-to-female transgender patient experienced prolonged apnea post-ECT.
  • The patient was undergoing estrogen therapy for gender transition.
  • Laboratory tests revealed reduced serum pseudocholinesterase activity.

Findings:

  • Estrogen supplementation in transgender patients can decrease pseudocholinesterase levels.
  • Reduced pseudocholinesterase activity prolongs neuromuscular blockade from succinylcholine.
  • Succinylcholine dosage adjustment is necessary for transgender patients on estrogen therapy.

Implications:

  • Healthcare providers must consider hormonal therapies in transgender patients' care.
  • Anesthesiology teams need to be aware of potential drug interactions with estrogen.
  • Tailored neuromuscular blockade strategies are crucial for transgender patient safety during ECT.